BSE filing, NSE: EMMESSA. Summary written from the filing by ALFA Finder's alert engine.
Emmessar Biotech & Nutrition Ltd: key numbers
- Share price
- ₹23.63
- Market cap
- ₹11.81 Cr
- Revenue (annual)
- ₹0.37 Cr
- Net profit (annual)
- ₹0.44 Cr
- P/E (TTM)
- 29.8×Sector 52.8×
- Promoter holding
- 59.53%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emmessar Biotech & Nutrition Ltd
All →Emmessar Biotech & Nutrition Board Meeting Date
Emmessar Biotech & Nutrition scheduled a board meeting for 31 October 2026 to consider unaudited quarterly results ended 30 September 2026. The trading window stays closed until 02 November 2026.
Emmessar Biotech & Nutrition Other Announcement
Emmessar Biotech & Nutrition Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory reporting standards.
Emmessar Biotech & Nutrition Annual General Meeting
Emmessar Biotech & Nutrition Ltd conducted its 34th Annual General Meeting on September 29, 2026. Key business included adopting financial statements and re-appointing directors.
Emmessar Biotech & Nutrition Other Announcement
Emmessar Biotech & Nutrition informed shareholders without registered email addresses about accessing the Annual Report and 34th AGM Notice via the company's website.
Emmessar Biotech & Nutrition Annual General Meeting
Emmessar Biotech & Nutrition Limited has issued a notice for its 34th Annual General Meeting, scheduled to be held on September 29, 2026, via video conferencing.
Emmessar Biotech & Nutrition Q1 FY27 Results: Net Profit ₹0.1 Cr, Down 50.0% YoY
Emmessar Biotech & Nutrition Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0.1 Cr (-50.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr · -50.0% YoY
Other debt & borrowing announcements
All →Signatureglobal (India) Debt & Borrowing
Signatureglobal disclosed corporate guarantees issued by its wholly owned subsidiaries to IndusInd Bank facilities. The guarantees secure Rs 150 crore, Rs 250 crore and Rs 398.3 crore of term loan facilities.
LIC Housing Finance Debt & Borrowing
LIC Housing Finance reported a 1.24x security cover on listed secured NCDs. It is a Regulation 54 certificate with no new event amount.
Religare Enterprises Debt & Borrowing: ₹150 Cr
Care Health Insurance, a material subsidiary of Religare, allotted listed subordinated debentures worth ₹150 Crore at a 10.50% coupon. The debentures mature in 2036, callable after five years.
- Value
- ₹150.0 Cr
Blue Coast Hotels Debt & Borrowing: ₹14.52 Cr
Blue Coast Hotels defaulted on Rs 14.52 crore principal and dividend on redeemable preference shares. Default occurred 30 October 2026, affecting unlisted debt holders.
- Value
- ₹14.52 Cr
Sammaan Capital Debt & Borrowing: ₹0.88 Cr
Sammaan Capital paid Rs.0.88 Crore of monthly interest on secured NCDs on October 30, 2026, ahead of the November 1 due date.
- Value
- ₹0.88 Cr
Sammaan Capital Debt & Borrowing: ₹0.58 Cr
Sammaan Capital certifies timely payment of Rs 0.58 crore interest on listed public-issue NCDs. The payment covers seven ISINs, with interest paid on October 30, 2026.
- Value
- ₹0.58 Cr